Articles Tagged With:
-
Viral Exposure and the Risk of Developing Neurodegenerative Disease
In two national European biobanks, researchers identified and replicated 22 pairs of viral exposures associated with a higher risk of neurodegenerative diseases.
-
New Tools Can Help Healthcare Industry Cut Carbon Emissions
Leaders can take advantage of loans, grants, and tax credits available through the Inflation Reduction Act.
-
Limiting Meal Size and Caloric Intake May Be More Beneficial Than Time-Restricted Eating
Researchers found monitoring total caloric intake may be more effective for losing weight than intermittent fasting.
-
More Steps Mean Better Cardiovascular Health for Older Americans
In a meta-analysis, researchers found walking 6,000 to 9,000 steps daily lowered the risk of cardiovascular disease by 40% to 50% vs. walking 2,000 steps daily.
-
Sitting, Standing, and Walking: The Effect on Cardiometabolic Markers
This meta-analysis explores the effects of interrupting sitting with either light-intensity walking or standing and finds that light-intensity walking is associated with the most significant impact on several markers of cardiometabolic health.
-
Infectious Disease Alert Updates
Occupational Mpox in Healthcare Workers; Homeless People at Risk for Mpox; PRIORIX Is Interchangeable with MMRII
-
Outbreak of Botulism Due to Intragastric Botulinum Toxin Injection for Weight Loss
An outbreak of botulism after intragastric injection of botulinum toxin to cause weight loss has, to date, affected at least 87 patients.
-
Challenges in Diagnosing MIS-C
Even though there are clear diagnostic criteria for multisystem inflammatory syndrome in children (MIS-C), the initial diagnosis is not always certain, and there can be overlapping concurrent bacterial, viral, and parasitic infections that also require prompt treatment.
-
SER-109 Improves Quality of Life Compared to Placebo in Patients with Recurrent Clostridioides difficile Infection
A secondary analysis of a Phase III clinical trial found SER-109 improved health-related quality of life for patients with recurrent C. difficile infection compared to placebo through eight weeks.
-
Shortening the Duration of Tuberculosis Treatment
In patients with rifampin-susceptible tuberculosis, a planned eight-week regimen of bedaquiline plus linezolid together with isoniazid, ethambutol, and pyrazinamide, combined with a careful follow-on strategy, was non-inferior to a standard six-month regimen.